ARS Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards
ARS Pharmaceuticals, Inc. (SPRY) had Deferred Tax Assets, Operating Loss Carryforwards of $32.25 million as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-09
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $32.25M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $12.83M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $16.13M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $8.25M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $32.25M 10-K · filed 2026-03-09 | |
| 2024-12-31 | $12.83M 10-K · filed 2026-03-09 | |
| 2023-12-31 | $16.13M 10-K · filed 2025-03-20 | |
| 2022-12-31 | $8.25M 10-K · filed 2024-03-21 | |
| 2021-12-31 | $5.46M 10-K · filed 2023-03-23 | $33.67M 10-K · filed 2022-03-31 |
| 2020-12-31 | $18.83M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |